Fetal Pulmonary Artery Acceleration to Ejection Time Ratio (PATET) in the Prediction of Subsequent Development of Respiratory Distress Syndrome (RDS)
1 other identifier
observational
115
0 countries
N/A
Brief Summary
Fetal PATET ratio evaluation to predict neonatal RDS
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2015
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
December 20, 2016
CompletedFirst Posted
Study publicly available on registry
January 2, 2017
CompletedJanuary 4, 2017
December 1, 2016
9 months
December 20, 2016
December 31, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of fetal pulmonary acceleration time to ejection time ratio via ultrasonography in the 115 pregnant women between 27 to 37 weeks of gestation for prediction of respiratory distress syndrome
The aim of this study is to obtain the effectiveness of fetal pulmonary artery acceleration time to ejection time ratio in fetal lung maturity evaluation
Ten months
Study Arms (2)
RDS +
postpartum RDS developed group
RDS -
postpartum RDS undeveloped group
Interventions
intrauterine fetal pulmonary artery acceleration time to ejection time ratio measurement via ultrasound
Eligibility Criteria
Pregnant women beyond 27 weeks
You may qualify if:
- pregnant women within the 27 weeks of gestation and beyond
You may not qualify if:
- patients who did not give birth within 3 days after the ultrasonographic doppler examination
- fetuses with Any congenital abnormalities
- amniotic fluid abnormalities
- any chronic maternal diseases or pregnancy complications such as;gestational diabetes mellitus,preeclampsia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Schenone MH, Samson JE, Jenkins L, Suhag A, Mari G. Predicting fetal lung maturity using the fetal pulmonary artery Doppler wave acceleration/ejection time ratio. Fetal Diagn Ther. 2014;36(3):208-14. doi: 10.1159/000358299. Epub 2014 Aug 13.
PMID: 25139576BACKGROUNDAzpurua H, Norwitz ER, Campbell KH, Funai EF, Pettker CM, Kleine M, Bahtiyar MO, Malkus H, Copel JA, Thung SF. Acceleration/ejection time ratio in the fetal pulmonary artery predicts fetal lung maturity. Am J Obstet Gynecol. 2010 Jul;203(1):40.e1-8. doi: 10.1016/j.ajog.2010.01.075. Epub 2010 Apr 24.
PMID: 20417479BACKGROUNDGuan Y, Li S, Luo G, Wang C, Norwitz ER, Fu Q, Tu X, Tian X, Zhu J. The role of doppler waveforms in the fetal main pulmonary artery in the prediction of neonatal respiratory distress syndrome. J Clin Ultrasound. 2015 Jul-Aug;43(6):375-83. doi: 10.1002/jcu.22219. Epub 2014 Aug 11.
PMID: 25110859BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Barıs Buke
Kayseri Education and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Pincipal Investigator
Study Record Dates
First Submitted
December 20, 2016
First Posted
January 2, 2017
Study Start
December 1, 2015
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
January 4, 2017
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will share
if necessary